The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 23, 2021

Filed:

Aug. 28, 2015
Applicant:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Inventors:

Xing Dai, Cranford, NJ (US);

Kallol Basu, Hillsborough, NJ (US);

Duane DeMong, Hanover, MA (US);

Sarah W. Li, Audubon, PA (US);

Michael Miller, Scotch Plains, NJ (US);

Jack D. Scott, Scotch Plains, NJ (US);

Andrew W. Stamford, Chatham, NJ (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); C07D 413/14 (2006.01); C07D 487/04 (2006.01); C07D 403/14 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); A61P 25/16 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61P 25/16 (2018.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/14 (2013.01); C07D 413/14 (2013.01);
Abstract

The present invention is directed to substituted certain reversed indazole compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R9, and A are as defined herein, which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.


Find Patent Forward Citations

Loading…